Texas Oncology - Central/South Texas — Austin, Texas

Texas Oncology - Central/South Texas is a clinical research site located in Austin, Texas, United States 78705.

Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.

Texas Oncology - Central/South Texas has participated in 7 clinical trials with 6 currently active.

Therapeutic areas: Follicular Lymphoma, Colon Cancer, Rectal Cancer.

Sponsors: Celgene, SCRI Development Innovations, LLC, Artios Pharma Ltd.

Sponsor Feasibility Report

Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Oncology - Central/South Texas?

Texas Oncology - Central/South Texas has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Oncology - Central/South Texas conducted?

Texas Oncology - Central/South Texas has 7 clinical trials on record, with 6 currently active. Their work covers Follicular Lymphoma, Colon Cancer, Rectal Cancer.

Is Texas Oncology - Central/South Texas accredited by Crixeo Health?

Yes — Texas Oncology - Central/South Texas holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Texas Oncology - Central/South Texas?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.